Training specializing in pneumology, key in achieving a clinical practice of excellence

laboratories Chiesi and the Spanish society for Pneumology and thoracic surgery (SEPAR) organized the “4th meeting for residents (R3 and R4): present and future in pneumology ”

– over 120 residents of Pneumology meet from 1 to 3 of” March, in Santiago de Compostela, with the objective of reviewing the basics of the neumológica clinic from a practical point of view

-the importance of holding such meetings is essential for the future pulmonologists may deepen their scientific knowledge

-the future of the Pneumology will mean a change in the way of exercising her. The pulmonologist should bring to the hospital a value added that it should reflect in excellence of the acute and chronic patient care, avoiding hospitalizations and improving outpatient care

Santiago de Compostela, March 2012.- with the aim of contributing to the formation of the residents of Pneumology, the pharmaceutical laboratories Chiesi Spain and the Spanish society for Pneumology and thoracic surgery (SEPAR) organized the “4th meeting for residents (R3 and R4): present and future in pneumology” directed to complete the preparation of this professional group.

The scientific coordination of the meeting is in charge of the SEPAR. For the Dr. Luis Pérez del Llano, Chief of service of Pneumology of Hospital Universitario Hula of Lugo and coordinator of the meeting training specializing in pneumology, at the present time, should enable the newly formed pulmonologists have capacity to make a practice of excellence and to work in any country in Europe if they have no possibility of doing so in Spain. ”

this activity directed to residents (R3 and R4) that completed specific training of postgraduate and initiate their activity as specialists, aims to review the current state of the disease, its prevalence and impact on health, ranging to occupy much of his activity as pulmonologists, and provide them with a vision of continuing professional development that starts from this point.

To the Coordinator of the meeting “the course of residents is designed to review the basics of the neumológica clinic from a practical point of view.” There will be expert speakers in each area of knowledge of the Pneumology, to develop case studies that allow a review of a wide range of topics (COPD; asthma, sleep, ventilation, cancer, etc.)”.

For its part, Carmen Basola, Director of institutional relations of Chiesi, stresses the relevance of the rapporteurs and notes that “this type of meetings are fundamental to the future pulmonologists may deepen their scientific knowledge”.

Neumológicas diseases more prevalent

Neumológicas diseases most prevalent are COPD, asthma, and in the sleep apnea syndrome the first two are closely linked with the environmental and social conditions and the third depends on the increase in obesity in the developed countries ”, says Dr. Pérez.

The Coordinator also explains that currently need greater awareness of patients about the proper use of existing treatments, but not only by patients (those who will have to request that they comply with the established treatment) but also by doctors themselves, that we must prescribe the treatment that has shown more efficient in each case. The culture of sobremedicar patients must stop ”.

The future of the Pneumology

According to Dr. Pérez, the future of the Pneumology is fascinating. We are in a time of revolution in many of our diseases Star (COPD, asthma, pulmonary fibrosis, etc.) and also by the development of the techniques of neumológica intervention (ventilation, bronchoscopy, pleuroscopia, etc) ”.

The pulmonologist should bring to the hospital a value added that it should reflect in excellence of the acute and chronic patient care, avoiding hospitalizations and improving patient care. To achieve this, the best way is to invest enough in training ”, adds.

Also, this expert explained that the future of the Pneumology will mean a change in the way of exercising her. Hospitalization must make room for an organization focused on the care of the patient with consultations, home and day hospitals. Pneumology plant will be a place in which a medicine of semicríticos with a high degree of specialization will be ”.

CHIESI

CHIESI laboratories is a pharmaceutical multinational headquartered in Parma (Italy) created more than 75 years ago. In recent years, its policy of promotion of r & d (which devotes 15% of the turnover) and new acquisitions have made possible that reach some sales exceeding EUR 1 billion in 2010. It has three floors of production (Italy, France and Brazil) and four research centres in Italy, France, Great Britain and United States. It has a strong presence in Europe (including Spain) and worldwide (United States, Brazil, Pakistan, China, Russia, Egypt and the Maghreb countries).